This segment focuses on the research, development, manufacturing, and sales of Traditional Chinese Medicine (TCM) products. Research and development activities include the formulation and clinical testing of various TCM remedies, leveraging traditional knowledge and modern scientific methods. Technologies and methodologies used involve extraction, purification, and standardization of herbal ingredients, as well as advanced manufacturing processes to ensure product quality and efficacy. Therapeutic areas covered include a wide range of conditions commonly treated with TCM, such as respiratory ailments, digestive disorders, and musculoskeletal problems. The patient impact is significant, as TCM offers alternative and complementary treatment options. Market positioning is strong in China, with a competitive advantage in its established brand recognition and distribution network. Future opportunities lie in expanding into international markets and integrating TCM with modern medicine. Regulatory and clinical aspects involve adherence to Chinese and international standards for herbal medicine production and clinical trials. Partnerships and collaborations may include collaborations with TCM research institutions and hospitals.

This segment is primarily involved in the wholesale, retail, import, and export of Western and Chinese medicines, medical apparatus, and instruments. The segment operates a network of retail chain pharmacy outlets, including Cai Zhi Lin, Jian Min, GPC Prescription Pharmacy, and Hainan Guangyao Chenfei Pharmaceutical Chain outlets, as well as retail stores. The focus is on providing a wide range of pharmaceutical products and medical devices to consumers and healthcare providers. This segment does not have significant R&D activities. Technologies and methodologies used include supply chain management, inventory control, and e-commerce platforms for online sales. The therapeutic areas covered are broad, encompassing all areas of medicine. The patient impact is direct, as this segment provides access to essential medications and healthcare products. Market positioning is strong in the Chinese market, with a well-established distribution network. Future opportunities include expanding the retail network, developing e-commerce capabilities, and offering value-added services such as medication counseling. Regulatory aspects involve compliance with pharmaceutical regulations and standards for drug distribution and sales.

This segment focuses on the research, development, production, and sale of beverages, food, healthcare products, and other health-related items. This includes products such as Ganoderma spore oil capsules, lozenges, and tortoise herb jelly. Research and development activities involve the formulation and testing of new health products, focusing on natural ingredients and traditional Chinese medicine principles. Technologies and methodologies used include extraction, formulation, and packaging technologies. Therapeutic areas include general health and wellness, with a focus on preventative care and nutritional supplements. The patient impact is on improving overall health and well-being. Market positioning is in the growing health and wellness market in China. Future opportunities include expanding the product portfolio, developing new distribution channels, and entering international markets. Regulatory aspects involve compliance with food and health product regulations. Partnerships and collaborations may include collaborations with food and beverage companies and health product distributors.

This segment includes investments in the health industry, such as medical care, health management, health preservation, and elderly care, as well as providing commercial and advertising services. This segment does not have significant R&D activities. Technologies and methodologies used include healthcare management systems and marketing strategies. Therapeutic areas include healthcare services and wellness programs. The patient impact is on providing access to healthcare services and promoting healthy lifestyles. Market positioning is in the growing healthcare services market in China. Future opportunities include expanding healthcare service offerings and developing new business models. Regulatory aspects involve compliance with healthcare regulations. Partnerships and collaborations may include collaborations with hospitals, clinics, and healthcare providers.